Drugs / Biovance
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02521402 | Aug 2015 → Dec 2016 | keloid | Golla Center for Plastic Surgery | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Biovance | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02521402 ↗ |
| Modality | Other / unclassified | “Biovance, a Dehydrated Decellularized Human Amnion Membrane Allograft” NCT02521402 ↗ |
| Route | Other | “the Biovance will be laid in the base of the wound” NCT02521402 ↗ |